About InterValve
InterValve is a Healthcare company based in Minneapolis (United States) founded in 2008, and was acquired by Venus MedTech in June 2017. It operates as an aortic valvuloplasty balloons are developed for valve stenosis treatment. InterValve has raised $11.13 million across 4 funding rounds from investors including Venus MedTech and Oxford Finance. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is InterValve Inc. Its competitors include Insightra, Laguna Tech USA, TNMI, Hybernia Medical and AR Baltic Medical and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
InterValve was founded in 2008 and is based in Minneapolis, United States. Medical devices for percutaneous and trans-apical aortic valve replacement procedures are developed by the company within the cardiology sector. The main product, V8, functions as an aortic valvuloplasty balloon catheter targeted at calcified aortic valve stenosis. Regulatory approval for V8 sales has been secured, supporting clinical applications in valve treatments.
- Headquarters Minneapolis, United States
- SectorsHealthcare
- Website intervalveinc.com
- Social LinkedIn
- Acquired by Venus MedTech (Jun 2017)
- Legal Name Intervalve Inc
- Total Equity Funding$11.13M (USD)
in 4 rounds
- Latest Funding Round$3M (USD), Debt – Conventional
Jan 2015
- InvestorsVenus MedTech
& 1 more
- Acquired byVenus MedTech
(Jun 2017)
Funding Insights of InterValve
InterValve has successfully raised a total of $11.13M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.13M
- Total Rounds 4
- Last Round Debt – Conventional — $3M
- First Round $5.99M
(Feb 2012)
- Investors Count 1
All 4 funding rounds of InterValve with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | $3M | Debt – Conventional | – | – | |
| Aug 2014 | $2.57M | Series A | – | – | – |
| Jul 2013 | $2.57M | Series A | – | – | – |
| Feb 2012 | $5.99M | Series A | – | – | – |
2 investors in total: 2 institutional.
Investors in InterValve
InterValve has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Venus MedTech and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures. | 2009 | venusmedtech.com | Hangzhou, China |
Investor details for InterValve
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of InterValve
4 dated milestones of InterValve across 9 years, from founding to its latest funding, stage changes and deals.
- Founded InterValve is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Debt – Conventional, of $3.0M.
- Exit Acquired by Venus MedTech.
Competitors of InterValve
InterValve has 9 listed competitors in our database, 4 of them funded. They include Insightra, Laguna Tech USA, TNMI, Hybernia Medical and AR Baltic Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insightra.com | 2001 | Irvine, United States | $19.96M | 8 | Intra-aortic balloon catheters are developed for cardiology surgeries. | |
| lagunatechmed.com | 2021 | Irvine, United States | – | – | Heart valve systems are developed to treat valve regurgitation. | |
| tn-mi.com | 2001 | Clarksville, United States | – | – | Medical devices are developed and manufactured for surgical procedures. | |
| hyberniamedical.com | 2006 | Uniondale, United States | $3.71M | – | Solutions for acute ischemic stroke treatment are developed. | |
| arbalticmed.com | 2019 | Vilnius, Lithuania | – | – | Manufactures medical devices like drug-coated balloons for healthcare applications. | |
| lutonix.com | 2007 | Minneapolis, United States | $35M | – | Drug-coated balloon catheters are developed for vascular lesion treatments. | |
| anchorballoon.com | 2019 | Kalamazoo, United States | – | – | Creates innovative medical devices for cardiovascular and interventional procedures. | |
| synapticmed.com | 2005 | Lake Forest, United States | $60M | – | Medical devices for cardiac arrhythmias and cardiovascular diseases are developed. | |
| hicicarescience.com | 2019 | Mountain View, United States | – | – | Develops innovative interventional medical devices for treating special and complex lesions. |
Detailed competitors of InterValve
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as InterValve (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about InterValve
InterValve was founded in 2008 and raised its 1st funding round 4 years after it was founded.
InterValve is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
InterValve is a funded company, having raised a total of $11.13M across 4 funding rounds to date. The company's 1st funding round was a Series A of $5.99M, raised on Feb 2012.
InterValve was founded in 2008 and is based in Minneapolis, United States. Medical devices for percutaneous and trans-apical aortic valve replacement procedures are developed by the company within the cardiology sector. The main product, V8, functions as an aortic valvuloplasty balloon catheter targeted at calcified aortic valve stenosis. Regulatory approval for V8 sales has been secured, supporting clinical applications in valve treatments.
InterValve's top competitors include Insightra, Synaptic Medical and Lutonix.
InterValve has 2 investors. Key investors include Venus MedTech, and Oxford Finance.
InterValve operates through Intervalve Inc.
Yes. InterValve was acquired by Venus MedTech in June 2017.